{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T13:01:32Z","timestamp":1772456492044,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,21]]},"DOI":"10.7759\/cureus.35284","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T05:36:47Z","timestamp":1677044207000},"source":"Crossref","is-referenced-by-count":7,"title":["Study of the Mechanisms and Therapeutic Approaches of Migraine in Women and Pregnancy: A Literature Review"],"prefix":"10.7759","author":[{"given":"Jimmy","family":"Barus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey","family":"Sudharta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dini","family":"Adriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Institute for Health Metrics and Evaluation. GBD Compare - Indonesia. (2019). Accessed. January 28, 2023: https:\/\/vizhub.healthdata.org\/gbd-compare\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01402-2","article-title":"The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates","volume":"23","author":"Stovner LJ","year":"2022","unstructured":"Stovner LJ, Hagen K, Linde M, Steiner TJ. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain. 2022, 23:34. 10.1186\/s10194-022-01402-2","journal-title":"J Headache Pain"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000252808.97649.21","article-title":"Migraine prevalence, disease burden, and the need for preventive therapy","volume":"68","author":"Lipton RB","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007, 68:343-9. 10.1212\/01.wnl.0000252808.97649.21","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01666.x","article-title":"Cumulative lifetime migraine incidence in women and men","volume":"28","author":"Stewart WF","year":"2008","unstructured":"Stewart WF, Wood C, Reed ML, Roy J, Lipton RB. Cumulative lifetime migraine incidence in women and men. Cephalalgia. 2008, 28:1170-8. 10.1111\/j.1468-2982.2008.01666.x","journal-title":"Cephalalgia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2991\/iconprocs-19.2019.35","article-title":"Migraine prevalence and treatment in students of Yogyakarta State University","author":"Mazaya Q","year":"2019","unstructured":"Mazaya Q, Kushartanti W. Migraine prevalence and treatment in students of Yogyakarta State University. Proceedings of the First International Conference on Progressive Civil Society (ICONPROCS 2019). Atlantis Press, Amsterdam, Netherlands; 2019. 169-71. 10.2991\/iconprocs-19.2019.35"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202","article-title":"The International Classification of Headache Disorders, 3rd edition","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018, 38:1-211. 10.1177\/0333102417738202","journal-title":"Cephalalgia"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2002.02050.x","article-title":"Prevalence of menstrually related migraine and nonmigraine primary headache in female students of Belgrade University","volume":"42","author":"Dzoljic E","year":"2002","unstructured":"Dzoljic E, Sipetic S, Vlajinac H, Marinkovic J, Brzakovic B, Pokrajac M, Kostic V. Prevalence of menstrually related migraine and nonmigraine primary headache in female students of Belgrade University. Headache. 2002, 42:185-93. 10.1046\/j.1526-4610.2002.02050.x","journal-title":"Headache"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1995.015002140.x","article-title":"Sex-hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura","volume":"15","author":"Cupini LM","year":"1995","unstructured":"Cupini LM, Matteis M, Troisi E, Calabresi P, Bernardi G, Silvestrini M. Sex-hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia. 1995, 15:140-4. 10.1046\/j.1468-2982.1995.015002140.x","journal-title":"Cephalalgia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S282562","article-title":"Exploring the hereditary nature of migraine","volume":"17","author":"Bron C","year":"2021","unstructured":"Bron C, Sutherland HG, Griffiths LR. Exploring the hereditary nature of migraine. Neuropsychiatr Dis Treat. 2021, 17:1183-94. 10.2147\/NDT.S282562","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000624","article-title":"The migraine premonitory phase","volume":"24","author":"Karsan N","year":"2018","unstructured":"Karsan N, Bose P, Goadsby PJ. The migraine premonitory phase. Continuum (Minneap Minn). 2018, 24:996-1008. 10.1212\/CON.0000000000000624","journal-title":"Continuum (Minneap Minn)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt320","article-title":"Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks","volume":"137","author":"Maniyar FH","year":"2014","unstructured":"Maniyar FH, Sprenger T, Monteith T, Schankin C, Goadsby PJ. Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain. 2014, 137:232-41. 10.1093\/brain\/awt320","journal-title":"Brain"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww097","article-title":"The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks","volume":"139","author":"Schulte LH","year":"2016","unstructured":"Schulte LH, May A. The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain. 2016, 139:1987-93. 10.1093\/brain\/aww097","journal-title":"Brain"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103929","article-title":"Neurochemical pathways that converge on thalamic trigeminovascular neurons: potential substrate for modulation of migraine by sleep, food intake, stress and anxiety","volume":"9","author":"Noseda R","year":"2014","unstructured":"Noseda R, Kainz V, Borsook D, Burstein R. Neurochemical pathways that converge on thalamic trigeminovascular neurons: potential substrate for modulation of migraine by sleep, food intake, stress and anxiety. PLoS One. 2014, 9:e103929. 10.1371\/journal.pone.0103929","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/cne.20688","article-title":"Unitary hypothesis for multiple triggers of the pain and strain of migraine","volume":"493","author":"Burstein R","year":"2005","unstructured":"Burstein R, Jakubowski M. Unitary hypothesis for multiple triggers of the pain and strain of migraine. J Comp Neurol. 2005, 493:9-14. 10.1002\/cne.20688","journal-title":"J Comp Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-030212-183717","article-title":"Pathophysiology of migraine","volume":"75","author":"Pietrobon D","year":"2013","unstructured":"Pietrobon D, Moskowitz MA. Pathophysiology of migraine. Annu Rev Physiol. 2013, 75:365-91. 10.1146\/annurev-physiol-030212-183717","journal-title":"Annu Rev Physiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1126\/science.1231897","article-title":"Spreading depression triggers headache by activating neuronal Panx1 channels","volume":"339","author":"Karatas H","year":"2013","unstructured":"Karatas H, Erdener SE, Gursoy-Ozdemir Y, Lule S, Eren-Ko\u00e7ak E, Sen ZD, Dalkara T. Spreading depression triggers headache by activating neuronal Panx1 channels. Science. 2013, 339:1092-5. 10.1126\/science.1231897","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0511-10.2010","article-title":"Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura","volume":"30","author":"Zhang X","year":"2010","unstructured":"Zhang X, Levy D, Noseda R, Kainz V, Jakubowski M, Burstein R. Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura. J Neurosci. 2010, 30:8807-14. 10.1523\/JNEUROSCI.0511-10.2010","journal-title":"J Neurosci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00034.2015","article-title":"Pathophysiology of migraine: a disorder of sensory processing","volume":"97","author":"Goadsby PJ","year":"2017","unstructured":"Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017, 97:553-622. 10.1152\/physrev.00034.2015","journal-title":"Physiol Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0373-15.2015","article-title":"Migraine: multiple processes, complex pathophysiology","volume":"35","author":"Burstein R","year":"2015","unstructured":"Burstein R, Noseda R, Borsook D. Migraine: multiple processes, complex pathophysiology. J Neurosci. 2015, 35:6619-29. 10.1523\/JNEUROSCI.0373-15.2015","journal-title":"J Neurosci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3285-11.2011","article-title":"Cortical projections of functionally identified thalamic trigeminovascular neurons: implications for migraine headache and its associated symptoms","volume":"31","author":"Noseda R","year":"2011","unstructured":"Noseda R, Jakubowski M, Kainz V, Borsook D, Burstein R. Cortical projections of functionally identified thalamic trigeminovascular neurons: implications for migraine headache and its associated symptoms. J Neurosci. 2011, 31:14204-17. 10.1523\/JNEUROSCI.3285-11.2011","journal-title":"J Neurosci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2005.4501001.x","article-title":"Migraine: epidemiology, impact, and risk factors for progression","volume":"45","author":"Lipton RB","year":"2005","unstructured":"Lipton RB, Bigal ME. Migraine: epidemiology, impact, and risk factors for progression. Headache. 2005, 45:S3-13. 10.1111\/j.1526-4610.2005.4501001.x","journal-title":"Headache"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-008-0024-z","article-title":"Prevalence and burden of primary headache in Akaki textile mill workers, Ethiopia","volume":"9","author":"Takele GM","year":"2008","unstructured":"Takele GM, Tekle Haimanot R, Martelletti P. Prevalence and burden of primary headache in Akaki textile mill workers, Ethiopia. J Headache Pain. 2008, 9:119-28. 10.1007\/s10194-008-0024-z","journal-title":"J Headache Pain"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(04)00768-9","article-title":"Oestrogen and attacks of migraine with and without aura","volume":"3","author":"MacGregor EA","year":"2004","unstructured":"MacGregor EA. Oestrogen and attacks of migraine with and without aura. Lancet Neurol. 2004, 3:354-61. 10.1016\/S1474-4422(04)00768-9","journal-title":"Lancet Neurol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.45.6.1076","article-title":"Relationship of headache to phase of the menstrual cycle among young women: a daily diary study","volume":"45","author":"Johannes CB","year":"1995","unstructured":"Johannes CB, Linet MS, Stewart WF, Celentano DD, Lipton RB, Szklo M. Relationship of headache to phase of the menstrual cycle among young women: a daily diary study. Neurology. 1995, 45:1076-82. 10.1212\/wnl.45.6.1076","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.55.10.1517","article-title":"Menstrual cycle and headache in a population sample of migraineurs","volume":"55","author":"Stewart WF","year":"2000","unstructured":"Stewart WF, Lipton RB, Chee E, Sawyer J, Silberstein SD. Menstrual cycle and headache in a population sample of migraineurs. Neurology. 2000, 55:1517-23. 10.1212\/wnl.55.10.1517","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2003.00516.x","article-title":"Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment","volume":"23","author":"Couturier EG","year":"2003","unstructured":"Couturier EG, Bomhof MA, Neven AK, van Duijn NP. Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia. 2003, 23:302-8. 10.1046\/j.1468-2982.2003.00516.x","journal-title":"Cephalalgia"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000233888.18228.19","article-title":"Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen","volume":"67","author":"MacGregor EA","year":"2006","unstructured":"MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology. 2006, 67:2154-8. 10.1212\/01.wnl.0000233888.18228.19","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.22.4.355","article-title":"The role of estradiol withdrawal in the etiology of menstrual migraine","volume":"22","author":"Somerville BW","year":"1972","unstructured":"Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology. 1972, 22:355-65. 10.1212\/wnl.22.4.355","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2005.05047.x","article-title":"Headaches in women undergoing in vitro fertilization and embryo-transfer treatment","volume":"45","author":"Amir BY","year":"2005","unstructured":"Amir BY, Yaacov B, Guy B, Gad P, Itzhak W, Gal I. Headaches in women undergoing in vitro fertilization and embryo-transfer treatment. Headache. 2005, 45:215-9. 10.1111\/j.1526-4610.2005.05047.x","journal-title":"Headache"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2002.122988","article-title":"Acceptance of altering the standard 21-day\/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms","volume":"186","author":"Sulak PJ","year":"2002","unstructured":"Sulak PJ, Kuehl TJ, Ortiz M, Shull BL. Acceptance of altering the standard 21-day\/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol. 2002, 186:1142-9. 10.1067\/mob.2002.122988","journal-title":"Am J Obstet Gynecol"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.1186\/1129-2377-16-S1-A24","article-title":"Migraine in pregnancy","volume":"16","author":"Sacco S","year":"2015","unstructured":"Sacco S, Ripa P. Migraine in pregnancy. J Headache Pain. 2015, 16:A24.","journal-title":"J Headache Pain"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1177\/0333102409360828","article-title":"Does single cortical spreading depression elicit pain behaviour in freely moving rats?","volume":"30","author":"Akcali D","year":"2010","unstructured":"Akcali D, Sayin A, Sara Y, Bolay H. Does single cortical spreading depression elicit pain behaviour in freely moving rats?. Cephalalgia. 2010, 30:1195-206. 10.1177\/0333102409360828","journal-title":"Cephalalgia"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(88)90690-7","article-title":"Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat","volume":"457","author":"Marrannes R","year":"1988","unstructured":"Marrannes R, Willems R, De Prins E, Wauquier A. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat. Brain Res. 1988, 457:226-40. 10.1016\/0006-8993(88)90690-7","journal-title":"Brain Res"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s10048-004-0181-4","article-title":"The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case\/control groups","volume":"5","author":"Colson NJ","year":"2004","unstructured":"Colson NJ, Lea RA, Quinlan S, MacMillan J, Griffiths LR. The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case\/control groups. Neurogenetics. 2004, 5:129-33. 10.1007\/s10048-004-0181-4","journal-title":"Neurogenetics"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s10048-004-0205-0","article-title":"Investigation of hormone receptor genes in migraine","volume":"6","author":"Colson NJ","year":"2005","unstructured":"Colson NJ, Lea RA, Quinlan S, MacMillan J, Griffiths LR. Investigation of hormone receptor genes in migraine. Neurogenetics. 2005, 6:17-23. 10.1007\/s10048-004-0205-0","journal-title":"Neurogenetics"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2000.00112.x","article-title":"Migraine with aura and reproductive life events: a case control study","volume":"20","author":"Granella F","year":"2000","unstructured":"Granella F, Sances G, Pucci E, Nappi RE, Ghiotto N, Napp G. Migraine with aura and reproductive life events: a case control study. Cephalalgia. 2000, 20:701-7. 10.1111\/j.1468-2982.2000.00112.x","journal-title":"Cephalalgia"},{"key":"ref37","unstructured":"American Migraine Foundation. Menstrual migraine and treatment prevention. (2021). Accessed. January 28, 2023: https:\/\/americanmigrainefoundation.org\/resource-library\/menstrual-migraine-treatment-and-prevention\/."},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2008.01093.x","article-title":"Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine","volume":"48","author":"Nett R","year":"2008","unstructured":"Nett R, Mannix LK, Mueller L, Rodgers A, Hustad CM, Skobieranda F, Ramsey KE. Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine. Headache. 2008, 48:1194-201. 10.1111\/j.1526-4610.2008.01093.x","journal-title":"Headache"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2010.01771.x","article-title":"Total migraine freedom, a potential primary endpoint to assess acute treatment in migraine: comparison to the current FDA requirement using the complete rizatriptan study database","volume":"51","author":"Rodgers AJ","year":"2011","unstructured":"Rodgers AJ, Hustad CM, Cady RK, Martin VT, Winner P, Ramsey KE, Ho TW. Total migraine freedom, a potential primary endpoint to assess acute treatment in migraine: comparison to the current FDA requirement using the complete rizatriptan study database. Headache. 2011, 51:356-68. 10.1111\/j.1526-4610.2010.01771.x","journal-title":"Headache"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2008.01092.x","article-title":"A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraine","volume":"48","author":"Bigal M","year":"2008","unstructured":"Bigal M, Sheftell F, Tepper S, Tepper D, Ho TW, Rapoport A. A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraine. Headache. 2008, 48:1286-93. 10.1111\/j.1526-4610.2008.01092.x","journal-title":"Headache"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2007.00947.x","article-title":"Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies","volume":"48","author":"Martin V","year":"2008","unstructured":"Martin V, Cady R, Mauskop A, et al.. Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies. Headache. 2008, 48:226-35. 10.1111\/j.1526-4610.2007.00947.x","journal-title":"Headache"},{"key":"ref42","unstructured":"British Association for the Study of Headache. National Headache Management System for Adults. (2019). https.\/\/www.bash.org.uk\/downloads\/guidelines2019\/01_BASHNationalHeadache_Management_SystemforAdults_2019_guideline_ve...."},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1177\/1756285609335537","article-title":"Menstrual migraine: therapeutic approaches","volume":"2","author":"Macgregor EA","year":"2009","unstructured":"Macgregor EA. Menstrual migraine: therapeutic approaches. Ther Adv Neurol Disord. 2009, 2:327-36. 10.1177\/1756285609335537","journal-title":"Ther Adv Neurol Disord"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3109\/09513598809023619","article-title":"Menstrual migraine: a double-blind trial of percutaneous estradiol","volume":"2","author":"Dennerstein L","year":"1988","unstructured":"Dennerstein L, Morse C, Burrows G, Oats J, Brown J, Smith M. Menstrual migraine: a double-blind trial of percutaneous estradiol. Gynecol Endocrinol. 1988, 2:113-20. 10.3109\/09513598809023619","journal-title":"Gynecol Endocrinol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1994.hed3402103.x","article-title":"Perimenstrual migraine: effect of Estraderm TTS and the value of contingent negative variation and exteroceptive temporalis muscle suppression test","volume":"34","author":"Smits MG","year":"1994","unstructured":"Smits MG, van der Meer YG, Pfeil JP, Rijnierse JJ, Vos AJ. Perimenstrual migraine: effect of Estraderm TTS and the value of contingent negative variation and exteroceptive temporalis muscle suppression test. Headache. 1994, 34:103-6. 10.1111\/j.1526-4610.1994.hed3402103.x","journal-title":"Headache"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.05.089","article-title":"Prevention of menstrual migraine with perimenstrual transdermal 17-\u03b2-estradiol: a randomized, placebo-controlled, double-blind crossover study","volume":"96","author":"Alm\u00e9n-Christensson A","year":"2011","unstructured":"Alm\u00e9n-Christensson A, Hammar M, Lindh-\u00c5strand L, Landtblom AM, Brynhildsen J. Prevention of menstrual migraine with perimenstrual transdermal 17-\u03b2-estradiol: a randomized, placebo-controlled, double-blind crossover study. Fertil Steril. 2011, 96:498-500.e1. 10.1016\/j.fertnstert.2011.05.089","journal-title":"Fertil Steril"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2013.02.001","article-title":"Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V\/DNG) in women with menstrually-related migraine (MRM)","volume":"88","author":"Nappi RE","year":"2013","unstructured":"Nappi RE, Terreno E, Sances G, et al.. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V\/DNG) in women with menstrually-related migraine (MRM). Contraception. 2013, 88:369-75. 10.1016\/j.contraception.2013.02.001","journal-title":"Contraception"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-004-0057-1","article-title":"Menstrual migraine: a review of prophylactic therapies","volume":"8","author":"Martin VT","year":"2004","unstructured":"Martin VT. Menstrual migraine: a review of prophylactic therapies. Curr Pain Headache Rep. 2004, 8:229-37. 10.1007\/s11916-004-0057-1","journal-title":"Curr Pain Headache Rep"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.15388\/Amed.2021.28.1.19","article-title":"De novo migraine with aura in the third trimester of pregnancy: a case report and literature review","volume":"28","author":"Pa\u0161kevi\u010di\u016bt\u0117 E","year":"2021","unstructured":"Pa\u0161kevi\u010di\u016bt\u0117 E, Bu\u017einskien\u0117 D, Ryli\u0161kien\u0117 K. De novo migraine with aura in the third trimester of pregnancy: a case report and literature review. Acta Med Litu. 2021, 28:145-52. 10.15388\/Amed.2021.28.1.19","journal-title":"Acta Med Litu"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(02)08778-0","article-title":"Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial","volume":"359","author":"Altman D","year":"2002","unstructured":"Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, Smith D. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002, 359:1877-90. 10.1016\/s0140-6736(02)08778-0","journal-title":"Lancet"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1673681","article-title":"Headache in pregnancy, the puerperium, and menopause","volume":"38","author":"Sader E","year":"2018","unstructured":"Sader E, Rayhill M. Headache in pregnancy, the puerperium, and menopause. Semin Neurol. 2018, 38:627-33. 10.1055\/s-0038-1673681","journal-title":"Semin Neurol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.25.6.396","article-title":"Birth defects following maternal exposure to ergotamine, beta blockers, and caffeine","volume":"25","author":"Hughes HE","year":"1988","unstructured":"Hughes HE, Goldstein DA. Birth defects following maternal exposure to ergotamine, beta blockers, and caffeine. J Med Genet. 1988, 25:396-9. 10.1136\/jmg.25.6.396","journal-title":"J Med Genet"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S203650","article-title":"Updated evaluation of IV dihydroergotamine (DHE) for refractory migraine: patient selection and special considerations","volume":"13","author":"Shafqat R","year":"2020","unstructured":"Shafqat R, Flores-Montanez Y, Delbono V, Nahas SJ. Updated evaluation of IV dihydroergotamine (DHE) for refractory migraine: patient selection and special considerations. J Pain Res. 2020, 13:859-64. 10.2147\/JPR.S203650","journal-title":"J Pain Res"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2012.02207.x","article-title":"Errata in \"triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian mother and child cohort study\"","volume":"52","author":"Nezvalov\u00e1-Henriksen K","year":"2012","unstructured":"Nezvalov\u00e1-Henriksen K, Spigset O, Nordeng HM. Errata in \"triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian mother and child cohort study\". Headache. 2012, 52:1319-20. 10.1111\/j.1526-4610.2012.02207.x","journal-title":"Headache"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1111\/head.12500","article-title":"Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis","volume":"55","author":"Marchenko A","year":"2015","unstructured":"Marchenko A, Etwel F, Olutunfese O, Nickel C, Koren G, Nulman I. Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis. Headache. 2015, 55:490-501. 10.1111\/head.12500","journal-title":"Headache"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2017.04.013","article-title":"A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes","volume":"43","author":"Bandoli G","year":"2017","unstructured":"Bandoli G, Palmsten K, Forbess Smith CJ, Chambers CD. A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes. Rheum Dis Clin North Am. 2017, 43:489-502. 10.1016\/j.rdc.2017.04.013","journal-title":"Rheum Dis Clin North Am"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-016-0634-9","article-title":"Managing migraine during pregnancy and lactation","volume":"16","author":"Wells RE","year":"2016","unstructured":"Wells RE, Turner DP, Lee M, Bishop L, Strauss L. Managing migraine during pregnancy and lactation. Curr Neurol Neurosci Rep. 2016, 16:40. 10.1007\/s11910-016-0634-9","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref58","article-title":"Chronic pain management in pregnancy and lactation","volume":"80","author":"Coluzzi F","year":"2014","unstructured":"Coluzzi F, Valensise H, Sacco M, Allegri M. Chronic pain management in pregnancy and lactation. Minerva Anestesiol. 2014, 80:211-24.","journal-title":"Minerva Anestesiol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00659","article-title":"Antidepressant use in depressed women during pregnancy and the risk of preterm birth: a systematic review and meta-analysis of 23 cohort studies","volume":"11","author":"Chang Q","year":"2020","unstructured":"Chang Q, Ma XY, Xu XR, Su H, Wu QJ, Zhao YH. Antidepressant use in depressed women during pregnancy and the risk of preterm birth: a systematic review and meta-analysis of 23 cohort studies. Front Pharmacol. 2020, 11:659. 10.3389\/fphar.2020.00659","journal-title":"Front Pharmacol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003945","article-title":"First-trimester exposure to benzodiazepines and risk of congenital malformations in offspring: a population-based cohort study in South Korea","volume":"19","author":"Noh Y","year":"2022","unstructured":"Noh Y, Lee H, Choi A, et al.. First-trimester exposure to benzodiazepines and risk of congenital malformations in offspring: a population-based cohort study in South Korea. PLoS Med. 2022, 19:e1003945. 10.1371\/journal.pmed.1003945","journal-title":"PLoS Med"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1177\/2168479018761638","article-title":"Risk of cleft lip and\/or palate associated with antiepileptic drugs: postmarketing safety signal detection and evaluation of information presented to prescribers and patients","volume":"53","author":"Rezaallah B","year":"2019","unstructured":"Rezaallah B, Lewis DJ, Zeilhofer HF, Berg BI. Risk of cleft lip and\/or palate associated with antiepileptic drugs: postmarketing safety signal detection and evaluation of information presented to prescribers and patients. Ther Innov Regul Sci. 2019, 53:110-9. 10.1177\/2168479018761638","journal-title":"Ther Innov Regul Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/135367-study-of-the-mechanisms-and-therapeutic-approaches-of-migraine-in-women-and-pregnancy-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:51:52Z","timestamp":1707508312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/135367-study-of-the-mechanisms-and-therapeutic-approaches-of-migraine-in-women-and-pregnancy-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":61,"URL":"https:\/\/doi.org\/10.7759\/cureus.35284","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,21]]}}}